Is Recipharm Uppsala AB FDA approved?

Recipharm Uppsala AB holds 1 FDA-registered establishment in Sweden. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Recipharm Uppsala AB's drugs manufactured?

The FDA register lists Uppsala. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.

Recipharm Uppsala AB

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 0
Live patents: 0
Countries: 1
Base: Sweden

Authorisation

Registered operations

Analytical testing1Active ingredient (API) manufacture1Labelling1Finished drug manufacture1Packaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Recipharm Uppsala AB	Bj�rkgatan 30, Uppsala, - SE-753 23, Sweden (SWE)	Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging	1000171246774341221

Neighbours

Registered in the same town

Eurofins BioPharma Product Testing Sweden ABUppsala, SWE · 2 sites
Fresenius Kabi USA, LLCUppsala, SWE
Novavax, Inc.Uppsala, SWE

Compare

Comparable companies in Sweden

Cambrex Karlskoga AB1 site · 13 NDC
PolyPeptide Laboratories Sweden AB1 site · 9 NDC
Sever Pharma Solutions AB1 site · 1 NDC
Eurofins BioPharma Product Testing Sweden AB2 sites · 0 NDC
Apotek Produktion & Laboratorier AB3 sites · 0 NDC

Enquiry

Common questions

Is Recipharm Uppsala AB FDA approved?: Recipharm Uppsala AB holds 1 FDA-registered establishment in Sweden. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Recipharm Uppsala AB's drugs manufactured?: The FDA register lists Uppsala. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.